Indication Mapping
Identify High-Value Indications for Stronger Market Entry
We help you answer the fundamental questions:
Which medical conditions offer the highest commercial and clinical impact for my product?
Where are the unmet needs that my technology can uniquely fulfill?
How does the competitive and regulatory landscape differ between indications?
Which indications should I prioritize for development, investment, and launch?
How Cetas Healthcare Performs Indication & Mapping
Literature Evidence Review
Medical journals, clinical trial registries, treatment guidelines, and key opinion leader insights.
Epidemiology Analysis
Prevalence, incidence, and patient demographics to assess true addressable populations.
Unmet Need Assessment
Gaps in current therapies, diagnostics, or care pathways.
Competitive Landscape Review
Existing products, pipeline devices, and key competitors mapped by indication.
Regulatory Pathway Evaluation
Approval requirements, timelines, and region-specific complexities.
Market Sizing & Forecasting
Estimating revenue potential over 3–5 years for each shortlisted indication.
Risk & Feasibility Analysis
Clinical, regulatory, and adoption barriers for each opportunity.
Stakeholder Mapping
Understanding HCPs, payers, patient groups, and policy influencers in each indication.
Strategic Recommendations
Prioritized opportunity map with clear go/no-go decisions.
Ongoing Tracking
Tracking medical, technological, and policy shifts to keep your roadmap relevant.
Case Studies
Customer Centric Marketing Plan Development
A global medical technology company that develops a broad range of medical devices and medical technology Establish a clear understanding of the customer market landscape, trends, opportunities, and potential pitfalls to formulate an effective commercial... Read More
Our Deliverables
A prioritized indication opportunity framework
Epidemiology, unmet need, and competitive analysis for each indication
Market size and forecast models by geography and therapy
Regulatory roadmaps for targeted indications
Risk and feasibility profiling
Clear go/no-go and prioritization recommendations
Have a Business Enquiry?
Contact Our MedTech Experts
Cetas Healthcare is the world’s leading boutique MedTech market research firm. We blend agency-grade research with strategic intelligence frameworks to track pipelines, regulatory shifts, clinical trials, and GTM strategies. As pioneers of ISO 14155-compliant PMCF surveys, we’ve managed 25,000+ patient case forms for Class II & III devices, helping clients secure CE certifications and stay ahead of EU MDR requirements.
Contact Us: communication@cetas-healthcare.com
Visit Our Pages
